Results 101 to 110 of about 824,404 (357)

Harm Reduction at Work [PDF]

open access: yes, 2011
Outlines how hiring and mobilizing people who use drugs helps improve harm reduction programs. Offers policies for the workplace; strategies for recruitment, training, supervision, support, discipline, and conflict resolution; and two case ...
Cheryl White, Raffi Balian
core  

Intention to Switch to Smokeless Tobacco Use among South African Smokers: Results from the 2007 South African Social Attitudes Survey [PDF]

open access: yes, 2014
Background: Some smokeless tobacco products (SLT) have been shown to be associated with only a fraction of the risks of cigarettes. This study assessed South African smokers’ interest in switching to a hypothetical reduced harm SLT product.
Agaku, Israel T., Ayo-Yusuf, Olalekan A.
core   +4 more sources

Reciprocal control of viral infection and phosphoinositide dynamics

open access: yesFEBS Letters, EarlyView.
Phosphoinositides, although scarce, regulate key cellular processes, including membrane dynamics and signaling. Viruses exploit these lipids to support their entry, replication, assembly, and egress. The central role of phosphoinositides in infection highlights phosphoinositide metabolism as a promising antiviral target.
Marie Déborah Bancilhon, Bruno Mesmin
wiley   +1 more source

Defending a Rule of Institutional Autonomy on No-Harm Grounds [PDF]

open access: yes, 2004
The argument I sketch here for institutional autonomy is basically empirical and agrees with Professor Hamilton in making harm-reduction the overriding social goal. The argument proceeds in two steps.
Tushnet, Mark V.
core   +2 more sources

The cost-effectiveness of harm reduction

open access: yesInternational Journal of Drug Policy, 2015
HIV prevalence worldwide among people who inject drugs (PWID) is around 19%. Harm reduction for PWID includes needle-syringe programs (NSPs) and opioid substitution therapy (OST) but often coupled with antiretroviral therapy (ART) for people living with HIV. Numerous studies have examined the effectiveness of each harm reduction strategy.
Wilson, David P.   +4 more
openaire   +4 more sources

Rad27/FEN1 prevents accumulation of Okazaki fragments and ribosomal DNA copy number changes

open access: yesFEBS Letters, EarlyView.
The budding yeast Rad27 is a structure‐specific endonuclease. Here, the authors reveal that Rad27 is crucial for maintaining the stability of the ribosomal RNA gene (rDNA) region. Rad27 deficiency leads to the accumulation of Okazaki fragments and changes in rDNA copy number.
Tsugumi Yamaji   +3 more
wiley   +1 more source

Supply-side reduction policy and drug-related harm [PDF]

open access: yes
Large-scale seizures of cocaine, heroin and amphetamine-type substances (ATS) do not result in any reduction in overdoses on these drugs or on arrests for use and possession of these drugs, according to this report.
Don Weatherburn   +4 more
core   +1 more source

Mitochondrial fatty acid oxidation is stimulated by red light irradiation

open access: yesFEBS Letters, EarlyView.
Light at different wavelengths has distinct effects on keratinocyte viability and metabolism. UVA light abrogates metabolic fluxes. Blue and green light have no effect on metabolic fluxes, while red light enhanced oxidative phosphorylation by promoting fatty acid oxidation. Keratinocytes are the primary constituents of sunlight‐exposed epidermis.
Manuel Alejandro Herrera   +4 more
wiley   +1 more source

Women, harm reduction, and HIV [PDF]

open access: yes, 2007
Based on a literature review, examines how gender affects women drug users' access to harm reduction, drug treatment, and sexual and reproductive health services -- and their risk of HIV infection.
Malinowska-Sempruch, Kasia   +1 more
core  

Online drug scenes and harm reduction from below as phronesis [PDF]

open access: yes, 2016
This article presents a theoretical critique of notion of harm reduction on the basis of an empirical investigation of a variety of online manifestations of drug culture.
Aristotle   +31 more
core   +1 more source

Home - About - Disclaimer - Privacy